For biopharmaceutical companies, gene therapies are an economic challenge. They are expensive to make yet the diseases the treat are rare, so manufacturers tend to charge a lot for them to generate ...
LONDON, Feb. 4, 2026 /PRNewswire/ -- VIPRE Security Group, a global leader and award-winning cybersecurity, privacy, and data protection company, releases its Q4 2025 Email Threat Trends Report.
Zhejiang Provincial Key Laboratory of Vector Biology and Pathogen Control, Huzhou University has the following research output in the current window (1 February 2025 - 31 January 2026) of the Nature ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results